This inventor holds 1 USPTO granted patent. Top assignee: Vasogen Ireland Limited. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: The Innovative Contributions of David Elsley
Introduction
David Elsley is a notable inventor based in Oakville, Canada. He has made significant strides in the field of medical treatments, particularly focusing on atherosclerosis. His innovative approach combines traditional therapies with novel methods to enhance patient outcomes.
Latest Patents
David Elsley holds a patent for a groundbreaking treatment aimed at addressing atherosclerosis. The patent, titled "Combined therapies for atherosclerosis treatment," presents a combination treatment designed to slow or halt the progression of atherosclerotic plaque deposits in mammalian patients. This treatment involves administering a cholesterol-lowering drug, such as a statin, alongside an aliquot of the patient's own blood, which has been treated ex vivo with various stressors, including oxidative environments, thermal stress, and UV light. This innovative approach has the potential to significantly improve the management of atherosclerosis.
Career Highlights
David Elsley is associated with Vasogen Ireland Limited, a company dedicated to advancing medical therapies. His work at Vasogen has allowed him to explore and develop innovative solutions for complex health issues, particularly in cardiovascular health. His contributions to the field have been recognized for their potential impact on patient care.
Conclusion
David Elsley's inventive work in atherosclerosis treatment exemplifies the intersection of innovation and healthcare. His patent reflects a commitment to improving patient outcomes through novel therapeutic approaches. The advancements he has made in this field are noteworthy and contribute to the ongoing evolution of medical treatments.